{"id":"alz002-ds","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T05:53:49.559Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123538,"model":"claude-sonnet-4-5-20250929"},"description":"ALZ002 DS is an investigational drug candidate being developed by AnnJi Pharmaceutical Co., Ltd. currently in Phase 1 clinical trials. Limited public information is available regarding its molecular target, mechanism of action, or specific therapeutic indications at this early stage of development.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT04392830","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers","status":"COMPLETED","sponsor":"AnnJi Pharmaceutical Co., Ltd.","startDate":"2020-05-11","conditions":"Healthy","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":50656,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["JM17"],"phase":"phase_1","status":"active","brandName":"ALZ002 DS","genericName":"ALZ002 DS","companyName":"AnnJi Pharmaceutical Co., Ltd.","companyId":"annji-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}